These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8426090)

  • 1. Three distinct cell phenotypes of induced-TNF cytotoxicity and their relationship to apoptosis.
    Woods KM; Chapes SK
    J Leukoc Biol; 1993 Jan; 53(1):37-44. PubMed ID: 8426090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of macrophage recognition and killing of SV40-transformed tumor cells that are "resistant" or "susceptible" to contact-mediated killing.
    Chapes SK; Duffin D; Paulsen AQ
    J Immunol; 1988 Jan; 140(2):589-96. PubMed ID: 2826595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of murine leukemia virus env gene proteins on macrophage-mediated cytotoxicity in vitro.
    Chapes SK; Takemoto LJ
    Life Sci Adv; 1991; 10():9-21. PubMed ID: 11538406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxicity of transformed cells but not normal cells by a sialoglycopeptide growth regulator in the presence of tumor necrosis factor.
    Woods KM; Fattaey H; Johnson TC; Chapes SK
    Biochem Biophys Res Commun; 1994 Nov; 205(1):215-20. PubMed ID: 7999026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage binding of cells resistant and sensitive to contact-dependent cytotoxicity.
    Rosenkrans CF; Chapes SK
    Cell Immunol; 1991 Mar; 133(1):187-95. PubMed ID: 1899360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus proteins on the plasma membrane of infected cells. III. Infection of peritoneal macrophages.
    Natuk RJ; Holowczak JA
    Virology; 1985 Dec; 147(2):354-72. PubMed ID: 3878029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic action between tumor necrosis factor-alpha and transforming growth factor type-beta: consequences for natural antitumor mechanisms.
    Schulz A; Bauer G
    Anticancer Res; 2000; 20(5B):3443-8. PubMed ID: 11131646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.
    Laster SM; Wood JG; Gooding LR
    J Immunol; 1988 Oct; 141(8):2629-34. PubMed ID: 3171180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion.
    Schreiber M; McFadden G
    Virology; 1994 Nov; 204(2):692-705. PubMed ID: 7941338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide.
    Nolop KB; Ryan US
    Am J Physiol; 1990 Aug; 259(2 Pt 1):L123-9. PubMed ID: 2382730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM; Porter DA; Huber SC; Cowan RG
    Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E1A, not human papillomavirus E7, sensitizes tumor cells to lysis by macrophages through nitric oxide- and TNF-alpha-dependent mechanisms despite up-regulation of 70-kDa heat shock protein.
    Miura TA; Morris K; Ryan S; Cook JL; Routes JM
    J Immunol; 2003 Apr; 170(8):4119-26. PubMed ID: 12682242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor.
    Descoteaux A; Matlashewski G
    J Immunol; 1990 Aug; 145(3):846-53. PubMed ID: 2115544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes.
    Horton TM; Tollefson AE; Wold WS; Gooding LR
    J Virol; 1990 Mar; 64(3):1250-5. PubMed ID: 2304142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α renders macrophages resistant to a range of cancer chemotherapeutic agents through NF-κB-mediated antagonism of apoptosis signalling.
    Lo SZY; Steer JH; Joyce DA
    Cancer Lett; 2011 Aug; 307(1):80-92. PubMed ID: 21482450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.
    Abu-Amer Y; Ross FP; Edwards J; Teitelbaum SL
    J Clin Invest; 1997 Sep; 100(6):1557-65. PubMed ID: 9294124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages.
    Duerksen-Hughes PJ; Day DB; Laster SM; Zachariades NA; Aquino L; Gooding LR
    J Immunol; 1992 Sep; 149(6):2114-22. PubMed ID: 1325525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
    Lidbury BA; Ramshaw IA; Sambhi SK
    Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
    Geppert TD; Whitehurst CE; Thompson P; Beutler B
    Mol Med; 1994 Nov; 1(1):93-103. PubMed ID: 8790605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Azacytidine specifically inhibits the NIH-3T3 PCD process induced by TNF-alpha and cycloheximide via affecting BCL-XL.
    Wang Q; Wang P; Zhou H; Hu Y; Xie C; Gao F; Ma N; Hou H; Zhang H; Li L
    J Cell Biochem; 2018 Feb; 119(2):1501-1510. PubMed ID: 28777484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.